Jamie R. Oliver

New York University

Papers

1

Total Citations

38

H-Index

1

About

Jamie R. Oliver is a leading surgical oncologist whose work centers on the adoption and safety of transoral robotic surgery (TORS) for oropharyngeal cancers. His most-cited study, published in 2021, provides a critical, population-level analysis of TORS following its FDA approval in 2009, examining how this minimally invasive technique was integrated into clinical practice and evaluating its safety profile for patients with oropharyngeal squamous cell carcinoma (OPSCC). By analyzing real-world outcomes, Oliver’s research has helped clarify the benefits and risks of robotic surgery in head and neck oncology, offering essential guidance for surgeons and institutions adopting this technology. His work has garnered 38 citations, reflecting its influence on surgical decision-making and patient safety standards. Beyond this landmark paper, Oliver’s contributions continue to shape the field of otolaryngology, advancing evidence-based approaches to cancer treatment. For students and researchers, his investigations highlight the critical intersection of surgical innovation and rigorous safety assessment, underscoring the importance of data-driven adoption of new technologies in oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
38
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers
38 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: New York University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago